Cameron Brink achieves visual freedom with the EVO implantable lenses

Basketball Player

Cameron Brink Testimonial Hero

Vision struggles on and off the court

Cameron Brink, a star on the women’s basketball team of Stanford University, faced the daily struggles of glasses and contacts, impacting both her personal and professional life.

Cam Brink4

EVO ICL: the game-changer

Cameron's vision problems started in the 5th grade when glasses became a part of her daily life. Later, her reliance on visual aids expanded to contacts, introducing a new set of challenges. For approximately 12 years, Cameron navigated the world through glasses and contacts. "I've been wearing glasses or contacts since I was in the 5th grade. And started to struggle with eye dryness and irritation. As a basketball player, I was constantly losing my contacts during games and practice!" The burden of being nearsighted became an accepted norm… until Cameron learned about the EVO Implantable Collamer® Lenses (EVO ICL).
Cameron's decision to correct her nearsightedness with the EVO ICL procedure was fueled by the desire to break free from the constraints of traditional vision correction methods. With EVO ICL, Cameron's life took a remarkable positive turn. "My life has changed for the better! I don't have to fumble with contacts anymore when I wake up or during the day, and my eyes aren't irritated anymore. Plus, I don't have to worry about losing lenses on the court!" The differences post-EVO ICL are noticeable. In Cameron's words, "my eyes aren't irritated and dry like they were when I wore contacts. And I love waking up in the morning seeing clearly." Cameron emphasizes the life-changing benefits that extend beyond the basketball court. Choosing EVO ICL was not just about vision correction; it was a lifestyle choice. "The time I save each day! Living a life free of contacts was a huge selling point; as well as the fact that the EVO lens implant is reversible if I ever need it."
The differences post-EVO ICL are noticeable. In Cameron's words, "my eyes aren't irritated and dry like they were when I wore contacts. And I love waking up in the morning seeing clearly." Cameron emphasizes the life-changing benefits that extend beyond the basketball court. Choosing EVO ICL was not just about vision correction; it was a lifestyle choice. "The time I save each day! Living a life free of contacts was a huge selling point; as well as the fact that the EVO lens implant is reversible if I ever need it."
Cam Brink1
Cam Brink Basketball
Cam Brink1

EVO ICL: the game-changer

Cameron's decision to correct her nearsightedness with the EVO ICL procedure was fueled by the desire to break free from the constraints of traditional vision correction methods. With EVO ICL, Cameron's life took a remarkable positive turn. "My life has changed for the better! I don't have to fumble with contacts anymore when I wake up or during the day, and my eyes aren't irritated anymore. Plus, I don't have to worry about losing lenses on the court!"

The differences post-EVO ICL are noticeable. In Cameron's words, "my eyes aren't irritated and dry like they were when I wore contacts. And I love waking up in the morning seeing clearly." Cameron emphasizes the life-changing benefits that extend beyond the basketball court. Choosing EVO ICL was not just about vision correction; it was a lifestyle choice. "The time I save each day! Living a life free of contacts was a huge selling point; as well as the fact that the EVO lens implant is reversible if I ever need it."

For those on the fence about EVO ICL, Cameron passionately encourages, "talk to your eye doctor today. It's truly a life-changing procedure!" Join her in experiencing the world with newfound clarity and confidence.

Ready to embrace a life without the hassle of glasses and contacts? Discover the possibilities with EVO ICL. Call an EVO advisor today to schedule an appointment with an eye doctor near you, and embark on your own journey towards visual freedom!

이보 ICL로 시력의 자유를 되찾을 준비가 되셨나요? 지금 내 주변에 상담 가능한 안과를 찾아보세요.

내 현재 위치 사용

주요 안전성 정보

이보 ICL은 -0.5 디옵터 ~ -18.0 디옵터의 근시를 효과적으로 교정하고, 이보 Toric ICL은 -0.5 디옵터 ~ -18.0 디옵터의 근시를 교정함과 동시에 0.5 디옵터 ~ 6.0 디옵터의 난시를 교정합니다.

이 범위의 근시가 있는 경우, 이보 ICL 렌즈삽입술은 안경이나 콘택트 렌즈 없이 원거리 시력을 향상시킬 수 있습니다. 이보 ICL 렌즈삽입술은 원거리 시력을 교정하기 때문에 돋보기의 필요성이 없어지는 것은 아닙니다. 돋보기를 이전에 사용한 적이 없더라도 언젠가 필요해질 수 있습니다.

이보 ICL 렌즈삽입술은 외과적 절차이므로 잠재적으로 심각한 위험이 따를 수 있습니다. 안과 전문의와 잠재적 위험에 대해 상담하십시오. 드물기는 하지만 합병증에는 추가 수술, 염증, 각막 뒷면의 세포 손실, 안압 상승, 백내장이 포함될 수 있습니다.

다음과 같은 경우 이보 ICL 렌즈삽입술을 받지 않아야 합니다.

  • 안과 의사가 귀하의 눈 모양이 이보 ICL 렌즈삽입술에 적합하지 않다고 결정한 경우
  • 귀하가 임신 중이거나 수유 중인 경우
  • 렌즈삽입술 당시, 안과 의사가 귀하 연령대의 최소 내피세포밀도를 충족하지 않는다고 결정한 경우
  • 안과 의사가 귀하의 시력이 안정적이지 않다고 결정한 경우

이보 ICL 렌즈삽입술을 고려하기 전 눈 검사를 받고 이보 ICL 렌즈삽입술, 특히 잠재적인 장점, 위험 및 합병증에 대해 안과 전문의와 상담해야 합니다. 수술 후 회복에 필요한 시간을 상의해야 합니다. 잠재적인 장점, 위험 및 합병증에 대한 추가 정보는 홈페이지를 참조하십시오.

참고문헌

국가 또는 지역 선택

Europe

AustriaBelgium - DutchBelgium - FrenchFranceGermanyItalyNetherlandsNorwayPortugalSloveniaSpainSwedenSwitzerlandUK & Ireland

North America

CanadaCanada - FrenchMexicoUnited StatesUnited States - 中文

Latin America

EnglishSpanishPortuguese

North Africa

ArabicFrench

Middle East

Middle East عربىMiddle East - فارسيMiddle East - English

Asia Pacific

AustraliaChina - 中国IndiaJapan - 日本New ZealandS. Korea - 대한민국South East Asia

참고자료

Home - 광고심의필: 조합-2022-04-030 (유효기간: 2025.02.07)

1. Gonzalo Carracedo, et al. The role of dinucleoside polyphosphates on the ocular surface and other eye structures. Prog Retin Eye Res. 2016 Nov;55:182-205. 2. Paul J Dougherty, et al. Refractive outcomes and safety of the implantable collamer lens in young low-to-moderate myopes. Clin Ophthalmol. 2017;11:273–277. 3. Gregory D. Parkhurst, et al. Phakic Intraocular Lens Implantation in United States Military Warfighters: A Retrospective Analysis of Early Clinical Outcomes of the EVO ICL. J Refract Surg. 2011;27(7);473-481. 4. Feingold et al. Biocompatible, optically transparent, ultraviolet light absorbing, polymeric material based upon collagen and method of making. USPTO June 8, 1999. 5. ICL in Treatment of Myopia (ITM) Study Group. Postoperative Inflammation after Implantation of the Implantable Contact Lens. Ophthalmology 2003;110:2335-2341. 6. Steven Schallhorn, MD et al. Night Driving Simulation in a Randomized Prospective Comparison of Visian Toric Implantable Collamer Lenses and Conventional PRK for Moderate to High Myopic Astigmatism. Journal of Refractive Surgery Vol.26, No. 5, 2010:321-326 7. Gregory D Parkhurst. A prospective comparison of phakic collamer lenses and wavefront-optimized laser-assisted in situ keratomileusis for correction of myopia. Clinical Ophthalmology 2016;10:1209-1215. 8. Donald R Sanders et al. United States Food and Drug Administration Clinical Trial of the Implantable Collamer Lens (ICL) for Moderate to High Myopia Three-Year Follow-up. Ophthalmology. 2004;111:1683–1692. 9. Elena Martines-plaze, et al. Effect of the EVO + Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life. Am J Ophthalmol. 2021;226:117-125. 10. Data on file. STAAR Surgical Annual Report.

이보 ICL이란? - 광고심의필: 조합-2022-04-031 (유효기간: 2025.02.07)

1. Feingold et al. Biocompatible, optically transparent, ultraviolet light absorbing, polymeric material based upon collagen and method of making. USPTO June 8, 1999. 2. ICL in Treatment of Myopia (ITM) Study Group. Postoperative Inflammation after Implantation of the Implantable Contact Lens. Ophthalmology 2003;110:2335-2341. 3. Risto J. Uusitalo, et al. Implantable contact lens for high myopia. J Cataract Refract Surg 2002(28):29-36. 4. Gregory D. Parkhurst, et al. Phakic Intraocular Lens Implantation in United States Military Warfighters: A Retrospective Analysis of Early Clinical Outcomes of the EVO ICL. J Refract Surg. 2011;27(7);473-481. 5. FDA. Before, During & After Surgery. https://www.fda.gov/medical-de... (as of 2021-12-24) 6. 윤재문 외. 난시교정용 후방 유수정체 안내렌즈 삽입술의 단기간 임상성적. 대한안과학회지. 2009;50(6):839-851. 7. Steven Schallhorn, MD et al. Night Driving Simulation in a Randomized Prospective Comparison of Visian Toric Implantable Collamer Lenses and Conventional PRK for Moderate to High Myopic Astigmatism. Journal of Refractive Surgery Vol.26, No. 5, 2010:321-326. 8. Gregory D Parkhurst. A prospective comparison of phakic collamer lenses and wavefront-optimized laser-assisted in situ keratomileusis for correction of myopia. Clinical Ophthalmology 2016;10:1209-1215. 9. Donald R Sanders et al. United States Food and Drug Administration Clinical Trial of the Implantable Collamer Lens (ICL) for Moderate to High Myopia Three-Year Follow-up. Ophthalmology. 2004;111:1683–1692.

이보 ICL의 장점(야간시력 개선) - 광고심의필: 조합-2022-04-032 (유효기간: 2025.02.07)

1. Steven Schallhorn, MD et al. Night Driving Simulation in a Randomized Prospective Comparison of Visian Toric Implantable Collamer Lenses and Conventional PRK for Moderate to High Myopic Astigmatism. Journal of Refractive Surgery Vol.26, No. 5, 2010:321-326. 2. Gregory D Parkhurst. A prospective comparison of phakic collamer lenses and wavefront-optimized laser-assisted in situ keratomileusis for correction of myopia. Clinical Ophthalmology 2016;10:1209-1215. 3. Donald R Sanders et al. United States Food and Drug Administration Clinical Trial of the Implantable Collamer Lens (ICL) for Moderate to High Myopia Three-Year Follow-up. Ophthalmology. 2004;111:1683–1692. 4. FDA. Before, During & After Surgery. https://www.fda.gov/medical-de... (as of 2021-12-24) 5. 윤재문 외. 난시교정용 후방 유수정체 안내렌즈 삽입술의 단기간 임상성적. 대한안과학회지. 2009;50(6):839-851.

이보 ICL의 장점(안구건조증이 걱정되세요?) - 광고심의필: 조합-2022-04-033 (유효기간: 2025.02.08)

1. Gregory D. Parkhurst, et al. Phakic Intraocular Lens Implantation in United States Military Warfighters: A Retrospective Analysis of Early Clinical Outcomes of the EVO ICL. J Refract Surg. 2011;27(7);473-481. 2. FDA. Before, During & After Surgery. https://www.fda.gov/medical-de... (as of 2021-12-24). 3. 윤재문 외. 난시교정용 후방 유수정체 안내렌즈 삽입술의 단기간 임상성적. 대한안과학회지. 2009;50(6):839-851.

이보 ICL의 장점(마치 내 눈 같은 편안함) - 광고심의필: 조합-2022-04-029 (유효기간: 2025.02.03)

1. FDA. Before, During & After Surgery. https://www.fda.gov/medical-de... (as of 2021-12-24). 2. 윤재문 외. 난시교정용 후방 유수정체 안내렌즈 삽입술의 단기간 임상성적. 대한안과학회지. 2009;50(6):839-851.

수술 과정 - 광고심의필: 조합-2022-04-034 (유효기간: 2025.02.03)

1. FDA. Before, During & After Surgery. https://www.fda.gov/medical-de... (as of 2021-12-24) 2. 윤재문 외. 난시교정용 후방 유수정체 안내렌즈 삽입술의 단기간 임상성적. 대한안과학회지. 2009;50(6):839-851. 3. Elena Martines-plaze, et al. Effect of the EVO + Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life. Am J Ophthalmol. 2021;226:117-125. 4. Data on file. STAAR Surgical Annual Report.

자주 묻는 질문 - 광고심의필: 조합-2022-04-035 (유효기간: 2025.02.03)

1. Feingold et al. Biocompatible, optically transparent, ultraviolet light absorbing, polymeric material based upon collagen and method of making. USPTO June 8, 1999. 2. ICL in Treatment of Myopia (ITM) Study Group. Postoperative Inflammation after Implantation of the Implantable Contact Lens. Ophthalmology 2003;110:2335-2341. 3. Risto J. Uusitalo, et al. Implantable contact lens for high myopia. J Cataract Refract Surg 2002(28):29-36. 4. Elena Martines-plaze, et al. Effect of the EVO + Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life. Am J Ophthalmol. 2021;226:117-125.

개인정보 수집 및 이용

이보 ICL 브로슈어 발송을 위한 최소한의 개인정보를 수집하고 이용합니다.

수집된 정보는 이메일 발송 외 다른 목적으로 이용되지 않으며, 서비스가 종료되거나 구독을 해지할 경우 즉시 파기됩니다.